Submitted by Anonymous (not verified) on 24 October 2024 - 14:52
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026
Source:
Pharmacovigilance Risk Assessment Committee (PRAC): 7 - 10 April 2026, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2026 to 10 April 2026